Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 21,813	$ 20,752
Short-term investments	46,010	54,307
Prepaid expenses and other current assets	2,616	2,381
Total current assets	70,439	77,440
Property and equipment, net	234	234
Operating lease right-of-use assets	576	385
Goodwill	17,245	17,625
Intangible asset	62,253	63,672
Other assets	8,467	8,466
Equity investments in Lighthouse Pharmaceuticals, Inc.	78	78
Total assets	159,292	167,900
Current liabilities:
Accounts payable	2,070	2,033
Short-term contingent consideration	4,748	4,103
Accrued expenses and other current liabilities	3,020	3,436
Total current liabilities	9,838	9,572
Long-term debt	13,518	13,429
Long-term operating lease liability	480	321
Long-term contingent consideration	55,503	53,603
Deferred tax liabilities	5,177	5,304
Other long-term liabilities	599	587
Total liabilities	85,115	82,816
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value, 10,000,000 authorized, (100,000 shares of which are designated as Series A Junior Participating Preferred Stock), no shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively.	0	0
Common stock, $0.001 par value, 100,000,000 shares authorized, 43,215,233 and 42,973,215 issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	43	43
Additional paid in capital	403,102	401,638
Accumulated other comprehensive income	1,825	3,047
Accumulated deficit	(330,793)	(319,644)
Total stockholders’ equity	74,177	85,084
Total liabilities and stockholders’ equity	$ 159,292	$ 167,900